Michael B. Streiff, MD

Professional Titles

• Medical Director, The Johns Hopkins Hospital Special Coagulation Laboratory
• Attending Physician, The Johns Hopkins Hospital Comprehensive Hemophilia Treatment Center
• Medical Director, The Johns Hopkins Anticoagulation Management Service and Outpatient Clinics

Primary Academic Title

Professor of Medicine

Background

Centers and Institutes

Armstrong Institute for Patient Safety and Quality

Videos

• 2017 Armstrong Award for Excellence in Quality and Safety - Michael Streiff

Additional Academic Titles

Associate Professor of Pathology

Research Interests

Prevention and Treatment of Venous Thromboembolism

Lab Website

Michael B. Streiff Lab

• The Michael B. Streiff Lab conducts clinical and laboratory research of thrombophilia associated with malignancy. We are interested in the application of novel coagulation assays to explore the pathogenesis of thrombosis and the development of strategies to enhance the clinical management of anti-thrombotic agents.

Selected Publications

• 1. Streiff, M.B. Vena Caval Filters: A Comprehensive Review. Blood 2000; 95(12): 3669-3677.
  2. Streiff MB, Ness PM. Acquired factor V inhibitors: a needless iatrogenic complication of bovine thrombin exposure. Transfusion 2002 ;42(1): 18-26.
  3. Streiff MB, Spivak JL. The diagnosis and management of polycythemia vera in the post-polycythemia vera study group era: A survey of American Society of Hematology (ASH) members practice patterns. Blood 2002; 99(4):1144-1149.
  4. Segal JB, Bolger DT, Jenckes MW, Krishnan JA, Streiff MB, Eng J, Tamariz LJ, Bass EB. Outpatient therapy with low molecular weight heparin for treatment of venous thromboembolism: a systematic review of efficacy, safety and costs. Am J Med 2003 115(4):298-308.
  5. Streiff MB, Segal J, Grossman SA, Kickler TS, Weir EG. ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas. Cancer 2004; 100(8):1717-1723
  6. Kim HS, Patra A, Khan J, Arepally A, Streiff MB. Transhepatic Catheter-directed Thrombectomy and Thrombolysis of Acute Superior Mesenteric Venous Thrombosis. J Vasc Intervent Radiol 2005 16(12):1685-91
  7. Streiff MB, Segal JB, Tamariz LJ, Jenckes MW, Bolger DT, Eng J, Krishnan JA, Bass EB. Duration of oral anticoagulation for venous thromboembolism: A systematic review of the literature. Am J Hematol 2006;81(9):684-91.
  8. Kim HS, Patra A, Paxton BE, Khan J, Streiff MB. Adjunctive Percutaneous Mechanical Thrombectomy For Lower Extremity Deep Vein Thrombosis: Clinical And Economic Outcomes. J Vasc Intervent Radiol 2006 ;17(7):1099-1104.
  9. Gerber DE, Segal JB, Salhotra A, Olivi A, Streiff MB. Venous thromboembolism occurs rarely in post-operative meningioma patients receiving combined modality prophylaxis. Cancer 2007; 109(2):300-305.
  10. Segal JB, Streiff MB, Hoffman LV, Thornton K, Bass EB. Management of venous thromboembolism with low molecular weight heparin, catheter-directed thrombolysis, vena cava filters, compression stockings and oral anticoagulants: a systematic review of the evidence. Ann Intern Med 2007;146(3):211-222.
  11. Ahonkhai AA, Gebo KA, Streiff MB, Moore RD, Segal JB. Venous Thromboembolism in Patients with HIV/AIDS: A Case-Control Study. J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):310-4.
  12. Kim HS, Young MJ, Narayan AK, Hong K, Liddell RP, Streiff MB. A Comparison of Clinical Outcomes with Retrievable and Permanent Inferior Vena Cava Filters. J Vasc Interv Radiol 2008; 19:393399.
  13. Gerber DE, Segal JB, Levy MY, Kane J, Jones RJ, Streiff MB. The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1,514 patients undergoing hematopoietic stem cell transplantation: Implications for VTE prevention. Blood 2008 Aug 1;112(3):504-10. 
  14. Biscup-Horn P, Streiff MB, Ulbrich T, Nesbit TW, Shermock KM. Impact of an Anticoagulation Management Service on Inpatient Clinical and Economic Outcomes. Ann Pharmacother 2008 Jun;42(6):777-82.
  15. Shermock KM, Connor JT, Lavallee DC and Streiff MB. Clinical decision-making as the basis for assessing agreement between measures of the International Normalized Ratio. J Thromb Haemost 2009 Jan;7(1):87-93. 

Honors

• Award for Outstanding Teaching by a Full-time Faculty Member, Osler Medical Housestaff, 1/1/06
• C. Lockard Conley Award in Hematology, Johns Hopkins University School of Medicine, Department of Medicine, Division of Hematology, 1/1/96
• ASCO Young Investigator Award, American Society of Oncology, 1/1/95
• William R. Bell Prize in Hematology, Johns Hopkins University School of Medicine, Department of Medicine, Division of Hematology, 1/1/94
• Leighton R. Cluff Award for the Most Exemplary Physician, University of Florida, 1/1/91
• Valedictorian, Summa cum Laude, Washington and Lee University, 1/1/83
• Fulbright Scholar, University of Ulm, West Germany, United States Department of State, Bureau of Educational and Cultural Affairs, 1/1/83

Memberships

• American College of Physicians, Member
• American Society of Hematology, Member
• International Society on Thrombosis and Haemostasis, Member

Professional Activities

National Comprehensive Cancer Center Network, Chairman